Navigation Links
RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
Date:1/29/2008

uman or animal consumption, irrigation and other uses.

"To accommodate the current and anticipated growth of our CFS division, late in 2007, RG Global relocated its headquarters to a larger, 10,000 sq. ft. facility in Anaheim," Mr. Jangbarwala noted. "Since that time, we've expanded our marketing and engineering staff to manage the increased interest in the CFS technology. We anticipate announcing additional CFS contracts resulting from our efforts in the current quarter."

$3 Million Insurance Settlement Received

RG Global received $3 million related to a claim on a key man insurance policy it held. A portion of the funds has been used to settle litigation with a previous holder of Company convertible notes. The remainder will be used to fund RG Global's continuing R&D and growth.

RG Global CEO Grant King said, "RG Global expects to have sufficient resources to successfully complete our transition from an R&D stage to commercialization of our intellectual property. We have used the insurance proceeds to eliminate convertible debt while covering normal operating expenses. More than 85% of the cost of our first CBM plant coming online during the second quarter 2008 has been paid for in cash. We anticipate our revenue stream will increase substantially starting 2nd quarter in 2008. Additionally, we are finalizing financing commitments from vendors, investors and prospective customers, which will enable us to fund and build more CBM plants rapidly upon receipt of plant contracts. We have designed the financing to minimize dilution and preserve shareholder value while enabling controlled expansion that will dramatically enhance revenues for RG Global."

About RG Global Lifestyles, Inc.

RG Global Lifestyles, Inc. develops and markets innovative technologies for water purification and wastewater treatment. Major energy production companies have selected RG's proven CFS technology to economically treat coal bed methane wastewater, ma
'/>"/>

SOURCE RG Global Lifestyles, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
3. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
4. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
5. PPD Expands Global Central Lab Services into China
6. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
7. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
10. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
11. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 GliaCure, a privately-held ... therapies for neurological and neuropsychiatric disorders based on ... of Alzheimer,s patients in a Phase 1b clinical ... compound developed as a potential disease-modifying treatment. GliaCure,s ... in that it both promotes the clearance of ...
(Date:5/4/2015)... 4, 2015 /PRNewswire/ - The Fight Against Cancer ... to announce the formation of Turnstone Biologics Inc. ... for cancer that harness the patient,s own immune ... collaboration between the Children,s Hospital of ... University, the Ontario Institute for Cancer Research (OICR), ...
(Date:5/4/2015)... , May 4, 2015  Soligenix, Inc. (OTCQB: SNGX) ... products that address unmet medical needs in the areas ... will be presenting preclinical data from three of its ... Science and Technology Conference on May 12-14, 2015 to ... 701 Convention Plaza, St. Louis MO ...
(Date:5/4/2015)... 4, 2015   Intrexon Corporation (NYSE: ... 2015 financial results after the market closes on May ... that day at 5:30 PM ET to discuss the ... The conference call may be accessed by dialing 1-888-346-3959 ... the "Intrexon Conference Call."  Participants may also access the ...
Breaking Biology Technology:GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2
... NV,(Euronext Brussels: THR), a biotechnology company focused on ... it has completed,patient enrolment for its Phase II ... is to evaluate the safety and preliminary efficacy ... four and twelve hours after the onset of ...
... 8, 2008 Dendreon Corporation,(Nasdaq: DNDN ) ... registered direct offering of 8.0 million shares of ... 8.0 million shares of its common,stock. Net proceeds ... Markets LLC served as sole placement agent for ...
... Ganeden Biotech,announced that Sustenex(TM), its all-natural daily ... capsule contains at least 2,billion live probiotic ... Bacillus coagulans designed to help promote immune ... designed to survive and,thrive in the digestive ...
Cached Biology Technology:ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 2ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 3Dendreon Announces Closing of Registered Direct Offering 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 3
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/1/2015)... BOSTON , April 1, 2015   Medisafe ... 1.5 million users across iOS and ... has begun integrating biofeedback into the platform to allow ... health outcomes. For the first time, patients will be ... missing a dose impacts important biometrics, such as glucose ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... A new study presages a real aim of genetics: to ... of individual genetic variants for individual health. The research team, ... six novel genetic variants that are associated with lipid levels, ... power of ,genetic microscopes, has increased because the methods are ...
... Mass. Dec. 3, 2008 Interleukin-12 is a ... the human immune system. Having either too much or ... development of many diseases, including some cancers and auto-immune ... modulating interleukin-12 levels could yield new therapies for those ...
... Babraham Institute near Cambridge, supported by the Alzheimer,s ... Research Council (BBSRC), have discovered that the brain,s ... of ageing such as Alzheimer,s disease. The findings ... . Alzheimer,s disease causes nerve cells in ...
Cached Biology News:The genetic heart of the lipids 2The genetic heart of the lipids 3Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants 2Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants 3Maintaining the brain's wiring in aging and disease 2
Mouse monoclonal antibody to FMN2 - formin 2...
Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
Rabbit polyclonal to SMARCA2 / BRM - ChIP Grade ( Abpromise for all tested applications). entrezGeneID: 6595 SwissProtID: P51531...
Determin interaction of your protein with Echelons lipids...
Biology Products: